Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Schrodinger, Inc.

Get SEC filing alerts via email and in your feed for Schrodinger, Inc.

SDGR

Schrodinger, Inc.

About Schrodinger, Inc.

Schrödinger, Inc. develops physics-based computational software for drug discovery and materials science. Its platform accelerates molecule design, prediction, and optimization, serving biopharmaceutical, industrial, and academic markets worldwide. The company collaborates with leading pharma firms, licensing its solutions and advancing proprietary drug programs. Its competitive edge lies in high-accuracy simulations, large-scale molecule evaluation, and a broad pipeline of collaborative and internal therapeutics.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from Schrodinger, Inc.

1
1
Schrodinger, Inc. Schrödinger Reports $58.6 Million Revenue in Q1 2026, Drug Discovery Revenue Surges 124%

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
Schrodinger, Inc. Schrödinger, Inc. Reports Fiscal Year 2025 Results with Revenue Growth and Strategic Partnership Focus

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
Schrodinger, Inc. Schrödinger Reports 54% Revenue Growth to $54.3 Million, Net Loss Narrows

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
Schrodinger, Inc. Schrödinger Reports 16% Revenue Growth to $54.8 Million in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
Schrodinger, Inc. Schrödinger Reports 63% Revenue Growth to $59.6 Million, Net Loss Increases

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
Schrodinger, Inc. Schrödinger, Inc. Reports 17% Decline in Revenue for Q3 2024, Net Loss Improves

Via official filing (AI summary) | over 1 year ago | 0 comments